These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 19252271

  • 1. Roles of nicotinic receptors in acetylcholinesterase inhibitor-induced neuroprotection and nicotinic receptor up-regulation.
    Takada-Takatori Y, Kume T, Izumi Y, Ohgi Y, Niidome T, Fujii T, Sugimoto H, Akaike A.
    Biol Pharm Bull; 2009 Mar; 32(3):318-24. PubMed ID: 19252271
    [Abstract] [Full Text] [Related]

  • 2. [Mechanisms of neuroprotective effects of therapeutic acetylcholinesterase inhibitors used in treatment of Alzheimer's disease].
    Takatori Y.
    Yakugaku Zasshi; 2006 Aug; 126(8):607-16. PubMed ID: 16880719
    [Abstract] [Full Text] [Related]

  • 3. Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons.
    Kume T, Sugimoto M, Takada Y, Yamaguchi T, Yonezawa A, Katsuki H, Sugimoto H, Akaike A.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):77-85. PubMed ID: 16313899
    [Abstract] [Full Text] [Related]

  • 4. Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons.
    Takada Y, Yonezawa A, Kume T, Katsuki H, Kaneko S, Sugimoto H, Akaike A.
    J Pharmacol Exp Ther; 2003 Aug 19; 306(2):772-7. PubMed ID: 12734391
    [Abstract] [Full Text] [Related]

  • 5. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
    Arias E, Gallego-Sandín S, Villarroya M, García AG, López MG.
    J Pharmacol Exp Ther; 2005 Dec 19; 315(3):1346-53. PubMed ID: 16144975
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade.
    Takada-Takatori Y, Kume T, Sugimoto M, Katsuki H, Sugimoto H, Akaike A.
    Neuropharmacology; 2006 Sep 19; 51(3):474-86. PubMed ID: 16762377
    [Abstract] [Full Text] [Related]

  • 11. Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of alpha7 nicotinic receptors and internalization of NMDA receptors.
    Shen H, Kihara T, Hongo H, Wu X, Kem WR, Shimohama S, Akaike A, Niidome T, Sugimoto H.
    Br J Pharmacol; 2010 Sep 19; 161(1):127-39. PubMed ID: 20718745
    [Abstract] [Full Text] [Related]

  • 12. Preclinical evidence of neuroprotection by cholinesterase inhibitors.
    Akaike A.
    Alzheimer Dis Assoc Disord; 2006 Sep 19; 20(2 Suppl 1):S8-11. PubMed ID: 16772755
    [Abstract] [Full Text] [Related]

  • 13. Tacrine and donepezil attenuate the neurotoxic effect of A beta(25-35) in rat PC12 cells.
    Svensson AL, Nordberg A.
    Neuroreport; 1998 May 11; 9(7):1519-22. PubMed ID: 9631459
    [Abstract] [Full Text] [Related]

  • 14. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
    Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J.
    Drugs Aging; 2004 May 11; 21(7):453-78. PubMed ID: 15132713
    [Abstract] [Full Text] [Related]

  • 15. Neuroprotective effects of galanthamine and tacrine against glutamate neurotoxicity.
    Takada-Takatori Y, Kume T, Sugimoto M, Katsuki H, Niidome T, Sugimoto H, Fujii T, Okabe S, Akaike A.
    Eur J Pharmacol; 2006 Nov 07; 549(1-3):19-26. PubMed ID: 16996497
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protective effect of donepezil in a primary culture of rat cortical neurons exposed to oxygen-glucose deprivation.
    Akasofu S, Kosasa T, Kimura M, Kubota A.
    Eur J Pharmacol; 2003 Jul 04; 472(1-2):57-63. PubMed ID: 12860473
    [Abstract] [Full Text] [Related]

  • 18. Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors.
    Barnes CA, Meltzer J, Houston F, Orr G, McGann K, Wenk GL.
    Neuroscience; 2000 Jul 04; 99(1):17-23. PubMed ID: 10924948
    [Abstract] [Full Text] [Related]

  • 19. Novel dimeric acetylcholinesterase inhibitor bis7-tacrine, but not donepezil, prevents glutamate-induced neuronal apoptosis by blocking N-methyl-D-aspartate receptors.
    Li W, Pi R, Chan HH, Fu H, Lee NT, Tsang HW, Pu Y, Chang DC, Li C, Luo J, Xiong K, Li Z, Xue H, Carlier PR, Pang Y, Tsim KW, Li M, Han Y.
    J Biol Chem; 2005 May 06; 280(18):18179-88. PubMed ID: 15710623
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of chronic nicotine treatment-induced enhancement of the sensitivity of cortical neurons to the neuroprotective effect of donepezil in cortical neurons.
    Takada-Takatori Y, Kume T, Izumi Y, Niidome T, Fujii T, Sugimoto H, Akaike A.
    J Pharmacol Sci; 2010 May 06; 112(3):265-72. PubMed ID: 20173312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.